Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afrezza in Uncontrolled Type 2 Diabetes
NCT03324776Phase 3Completed
- Sponsor
- Model Clinical Research
- Start
- Oct 2017
- Primary completion
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by Model Clinical Research. Started Oct 2017; status: completed.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03324776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03324776.